- This event has passed.
Presenter(s): Mark Duncan, MD, Psychiatrist, Addiction Psychiatry, University of Washington Medical Center
Cost: No Fee
Target Audience: Physicians, nurse practitioners or other advanced practice nurses, PAs, psychologists, social workers, and healthcare teams.
Credit Designations Available: AMA PRA Category 1 Credit™, Nursing Contact Hours, AAPA Category 1 CME credit, CEUs for psychology, SW CE credit, and Interprofessional Continuing Education (IPCE) credit.
Webinar Description: There is a high prevalence of mental health disorders among those with opioid use disorder. However, many practitioners still find it difficult to distinguish between differential diagnoses that may have similar symptomatology, especially in regards to mental health and substance misuse. This webinar will enable participants to summarize the prevalence of common co-morbid mental illness, explain the relationships between concurrent mental health and opioid use disorder (OUD) and recognize risk factors associated with both mental health disorders and OUD.
Educational Objectives: To summarize the prevalence of common co-morbid mental health (MH) disorders, explain genetic and environmental relationship between concurrent MH disorders and OUD, and describe the impact that co-occurring mental health and opioid use disorders can have on treatment of both.
Accreditation and Certification of this activity
Joint Accreditation Statement
In support of improving patient care, this activity has been planned and implemented by American Academy of Addiction Psychiatry (AAAP) and American Psychiatric Association (APA). AAAP is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.
In 2020, AAAP also added accreditation from The American Academy of PAs (AAPA), American Psychological Association (APA), Association for Social Work Boards (ASWB) and American Dental Association (ADA).
Interprofessional Continuing Education (IPCE) Designation Statement
This activity was planned by and for the healthcare team, and learners will receive 1 Interprofessional Continuing Education credits for learning and change.
Physician Designation Statement
American Academy of Addiction Psychiatry designates this enduring material for a maximum of 1 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Nursing Designation Statement
American Academy of Addiction Psychiatry is an approved provider of nursing continuing education through AAAP’s Joint Accreditation provider #4008192. This activity is approved for up to 1 Nursing Contact Hours.
PA Designation Statement
American Academy of Addiction Psychiatry has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for a maximum of 1 AAPA Category 1 CME credits. PAs should only claim credit commensurate with the extent of their participation.
Psychologist Designation Statement
Continuing Education (CE) credits for psychologists are provided through AAAP’s Joint Accreditation provider #4008192. This activity is approved for 1 CEU hours.
Social Work Designation Statement
As a Jointly Accredited Organization, American Academy of Addiction Psychiatry (AAAP) is approved to offer social work continuing education by the Association of Social Work Boards (ASWB) Approved Continuing Education (ACE) program. Organizations, not individual courses are approved under this program. State and provincial regulatory boards have the final authority to determine whether an individual course may be accepted for continuing education credit. AAAP maintains responsibility for this course. Social workers completing this course receive 1 continuing education credit.